Arlene Weintraub is a science journalist and author with 20 years of experience writing about healthcare, pharmaceuticals and biotechnology.
Potential for Deals Drives a Big Surge in the Biotech Sector
Michael Thomenius of Epizyme, a new biopharmaceutical company in Cambridge, Mass., thought to be a prime takeover target.
8:28 p.m. | Updated
When Onyx Pharmaceuticals, a cancer drug de...